Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Risteli

Showing results (281-290 of 294) with videos related to

Pageof 30
Sort By:
British Journal of Cancer|November 1, 1993
p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progressionY Soini, T Turpeenniemi-Hujanen, D Kamel, et al.
Scandinavian Journal of Rheumatology|April 17, 2008
Combination drug strategy in recent-onset rheumatoid arthritis suppresses collagen I degradation and is associated with retardation of radiological progressionM Hakala, J Risteli, S Aman, et al.
Clinical and Experimental Rheumatology|April 1, 1988
Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritisK Hørslev-Petersen, K D Bentsen, P Halberg, et al.
Metabolism: Clinical and Experimental|February 1, 1991
The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormonesC Hassager, L T Jensen, J S Johansen, et al.
Annals of the Rheumatic Diseases|July 1, 1991
Markers of collagen and basement membrane metabolism in sera of patients with progressive systemic sclerosisN G Guseva, N V Anikina, R Myllylä, et al.
American Journal of Obstetrics and Gynecology|July 1, 1995
Macrophage colony-stimulating factor 1, a clinically useful tumor marker in endometrial adenocarcinoma: comparison with CA 125 and the aminoterminal propeptide of type III procollagenA Hakala, B M Kacinski, E R Stanley, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 13, 2000
Decreased protein C activation is associated with abnormal collagen turnover in the intraalveolar space of patients with interstitial lung diseaseH Yasui, E C Gabazza, O Taguchi, et al.
Cancer|May 1, 1999
Type I collagen metabolites as tumor markers in patients with lung carcinomaT Kobayashi, E C Gabazza, O Taguchi, et al.
Experimental Cell Research|June 18, 2010
Toll-like receptor 9 ligands enhance mesenchymal stem cell invasion and expression of matrix metalloprotease-13S Nurmenniemi, P Kuvaja, S Lehtonen, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1994
Genetic influences on type I collagen synthesis and degradation: further evidence for genetic regulation of bone turnoverA Tokita, P J Kelly, T V Nguyen, et al.
Pageof 30

Showing results (281-290 of 294) with videos related to

Sort By:
Pageof 30
British Journal of Cancer|November 1, 1993
p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progressionY Soini, T Turpeenniemi-Hujanen, D Kamel, et al.
Scandinavian Journal of Rheumatology|April 17, 2008
Combination drug strategy in recent-onset rheumatoid arthritis suppresses collagen I degradation and is associated with retardation of radiological progressionM Hakala, J Risteli, S Aman, et al.
Clinical and Experimental Rheumatology|April 1, 1988
Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritisK Hørslev-Petersen, K D Bentsen, P Halberg, et al.
Metabolism: Clinical and Experimental|February 1, 1991
The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormonesC Hassager, L T Jensen, J S Johansen, et al.
Annals of the Rheumatic Diseases|July 1, 1991
Markers of collagen and basement membrane metabolism in sera of patients with progressive systemic sclerosisN G Guseva, N V Anikina, R Myllylä, et al.
American Journal of Obstetrics and Gynecology|July 1, 1995
Macrophage colony-stimulating factor 1, a clinically useful tumor marker in endometrial adenocarcinoma: comparison with CA 125 and the aminoterminal propeptide of type III procollagenA Hakala, B M Kacinski, E R Stanley, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 13, 2000
Decreased protein C activation is associated with abnormal collagen turnover in the intraalveolar space of patients with interstitial lung diseaseH Yasui, E C Gabazza, O Taguchi, et al.
Cancer|May 1, 1999
Type I collagen metabolites as tumor markers in patients with lung carcinomaT Kobayashi, E C Gabazza, O Taguchi, et al.
Experimental Cell Research|June 18, 2010
Toll-like receptor 9 ligands enhance mesenchymal stem cell invasion and expression of matrix metalloprotease-13S Nurmenniemi, P Kuvaja, S Lehtonen, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1994
Genetic influences on type I collagen synthesis and degradation: further evidence for genetic regulation of bone turnoverA Tokita, P J Kelly, T V Nguyen, et al.
Pageof 30